The SMC decision regarding Migalastat (Galafold) was announced on 7 November 2016. The relevant Detailed Advice Document can be found here.
The October 2016 Fabry Newsletter is now available and can be downloaded here.
Please submit your email address to receive our next newsletter.
New oral therapy for Fabry patients in development, Read more on this..
May 16, 2018 1:21 pm
April is Fabry Disease Awareness Month. Find out what the members of the Fabry International Network are doing this… twitter.com/i/web/status/98657…
April 18, 2018 12:02 pm
Fabry International Network © 2013 - All rights reserved